Low IL-8 is associated with anxiety in suicidal patients: Genetic variation and decreased protein levels

Acta Psychiatrica Scandinavica

Volumn 131, Issue 4, 2015, Pages 269-278

  Janelidze, Shorena ^a   Suchankova, P ^b   Ekman, A ^b   Erhardt, S ^c   Sellgren, C ^c   Samuelsson, M ^d   Westrin, A ^a   Minthon, L ^e   Hansson, O ^e   Traskman Bendz L ^a   Brundin, L ^f,g  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

^e LUND UNIVERSITY   (Sweden)

^f MICHIGAN STATE UNIVERSITY   (United States)

^g VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

Biomarker; Chemokine; Depression; Inflammation

Indexed keywords

INTERLEUKIN 8; IL8 PROTEIN, HUMAN;

ADULT; ALLELE; ANXIETY; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDE ATTEMPT; BLOOD; COHORT ANALYSIS; GENETICS; METABOLISM; MIDDLE AGED; PSYCHOLOGY; SUICIDE;

ADULT; ANXIETY; COHORT STUDIES; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SUICIDE;

EID: 84924559946     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12339     Document Type: Article

References (66)

1. la Vecchia C, Lucchini F, Levi F. Worldwide trends in suicide mortality, 1955-1989. Acta Psychiatr Scand 1994;90:53-64.
2. Bertolote JM, Fleischmann A. Suicide and psychiatric diagnosis: a worldwide perspective. World Psychiatry 2002;1:181-185.
3. Hawton K, van Heeringen K. Suicide. Lancet 2009;373:1372-1381.
4. Moller HJ. Suicide, suicidality and suicide prevention in affective disorders. Acta Psychiatr Scand Suppl 2003;418:73-80.
5. Ernst C, Mechawar N, Turecki G. Suicide neurobiology. Prog Neurobiol 2009;89:315-333.
6. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-1049.
7. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008;14:6735-6741.
8. Kossmann T, Stahel PF, Lenzlinger PM et al. Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab 1997;17:280-289.
9. Weiss N, Deboux C, Chaverot N et al. IL8 and CXCL13 are potent chemokines for the recruitment of human neural precursor cells across brain endothelial cells. J Neuroimmunol 2010;223:131-134.
10. Araujo DM, Cotman CW. Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res 1993;600:49-55.
11. Saas P, Walker PR, Quiquerez AL et al. A self-defence mechanism of astrocytes against Fas-mediated death involving interleukin-8 and CXCR2. NeuroReport 2002;13:1921-1924.
12. Hussein MH, Daoud GA, Kakita H et al. High cerebrospinal fluid antioxidants and interleukin 8 are protective of hypoxic brain damage in newborns. Free Radic Res 2010;44:422-429.
13. Semple BD, Kossmann T, Morganti-Kossmann MC. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Metab 2010;30:459-473.
14. Isung J, Aeinehband S, Mobarrez F et al. Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters. Transl Psychiatry 2012;2:e196.
15. Lehto SM, Niskanen L, Herzig KH et al. Serum chemokine levels in major depressive disorder. Psychoneuroendocrinology 2010;35:226-232.
16. Eller T, Vasar V, Shlik J, Maron E. Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:445-450.
17. Simon NM, McNamara K, Chow CW et al. A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol 2008;18:230-233.
18. Song Y, Zhou D, Guan Z, Wang X. Disturbance of serum interleukin-2 and interleukin-8 levels in posttraumatic and non-posttraumatic stress disorder earthquake survivors in northern China. NeuroImmunoModulation 2007;14:248-254.
19. Hoge EA, Brandstetter K, Moshier S, Pollack MH, Wong KK, Simon NM. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety 2009;26:447-455.
20. Brietzke E, Kauer-Sant'anna M, Teixeira AL, Kapczinski F. Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder. Brain Behav Immun 2009;23:1079-1082.
21. Fillman SG, Cloonan N, Catts VS et al. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry 2013;18:206-214.
22. Maes M, Bocchio Chiavetto L, Bignotti S et al. Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophr Res 2002;54:281-291.
23. Zhang XY, Zhou DF, Zhang PY, Wu GY, Cao LY, Shen YC. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Schizophr Res 2002;57:247-258.
24. Brown AS, Hooton J, Schaefer CA et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 2004;161:889-895.
25. Ellman LM, Deicken RF, Vinogradov S et al. Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr Res 2010;121:46-54.
26. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000;55:1023-1027.
27. Gao LB, Pan XM, Jia J et al. IL-8 -251A/T polymorphism is associated with decreased cancer risk among population-based studies: evidence from a meta-analysis. Eur J Cancer 2010;46:1333-1343.
28. Zhang X, Zhang B, Zhang M et al. Interleukin-8 gene polymorphism is associated with acute coronary syndrome in the Chinese Han population. Cytokine 2011;56:188-191.
29. Ahn MH, Park BL, Lee SH et al. A promoter SNP rs4073T>A in the common allele of the interleukin 8 gene is associated with the development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode. Respir Res 2011;12:73.
30. Goverdhan SV, Ennis S, Hannan SR et al. Interleukin-8 promoter polymorphism -251A/T is a risk factor for age-related macular degeneration. Br J Ophthalmol 2008;92:537-540.
31. Liu S, Yi M, Wang M, Sun Y, Che F, Ma X. Association of IL8 -251A/T, IL12B -1188A/C and TNF-alpha -238A/G polymorphisms with Tourette syndrome in a family-based association study in a Chinese Han population. Neurosci Lett 2011;495:155-158.
32. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edn. Washington, DC: American Psychiatric Press, 1987.
33. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Press, 1994.
34. First M. Structured clinical interview for DSM-IV axis I disorders (SCID-I). Washington, DC: American Psychiatric Press, 1997.
35. First M. Structured clinical interview for DSM-IV axis II personality disorders (SCID-II). Washington, DC: American Psychiatric Press, 1997.
36. Spitzer RL, Williams JB, Gibbon M, First MB. Structured clinical interview for DSM-III-R, patient edition/non-patient edition, (SCID-P/SCID-NP). Washington, DC: American Psychiatric Press, Inc., 1990.
37. Spitzer RL, Williams JB, Gibbon M, First MB. Structured clinican interview for DSM-III-R axis II disorders, (SCID-II). Washington, DC: American Psychiatric Press, Inc., 1990.
38. Asberg M, Montgomery SA, Perris C, Schalling D, Sedvall G. A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl 1978;271:5-27.
39. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
40. Tyrer P, Owen RT, Cicchetti DV. The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale. J Neurol Neurosurg Psychiatry 1984;47:970-975.
41. Traskman-Bendz L, Ekman R, Regnell G, Ohman R. HPA-related CSF neuropeptides in suicide attempters. Eur Neuropsychopharmacol 1992;2:99-106.
42. Baghaei F, Rosmond R, Landen M et al. Phenotypic and genotypic characteristics of women in relation to personality traits. Int J Behav Med 2003;10:365-378.
43. Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998;83:1853-1859.
44. Uher T, Bob P. Cerebrospinal fluid IL-8 levels reflect symptoms of alexithymia in patients with non-inflammatory neurological disorders. Psychoneuroendocrinology 2011;36:1148-1153.
45. Hava G, Vered L, Yael M, Mordechai H, Mahoud H. Alterations in behavior in adult offspring mice following maternal inflammation during pregnancy. Dev Psychobiol 2006;48:162-168.
46. Shi L, Fatemi SH, Sidwell RW, Patterson PH. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003;23:297-302.
47. Connor TJ, Song C, Leonard BE, Merali Z, Anisman H. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 1998;84:923-933.
48. Koo JW, Duman RS. Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci Lett 2009;456:39-43.
49. Janelidze S, Mattei D, Westrin A, Traskman-Bendz L, Brundin L. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun 2011;25:335-339.
50. Lindqvist D, Janelidze S, Hagell P et al. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 2009;66:287-292.
51. Nassberger L, Traskman-Bendz L. Increased soluble interleukin-2 receptor concentrations in suicide attempters. Acta Psychiatr Scand 1993;88:48-52.
52. Tonelli LH, Stiller J, Rujescu D et al. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand 2008;117:198-206.
53. Janelidze S, Ventorp F, Erhardt S et al. Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters. Psychoneuroendocrinology 2013;38:853-862.
54. Sanacora G, Banasr M. From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry 2013;73:1172-1179.
55. Steiner J, Bielau H, Brisch R et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 2008;42:151-157.
56. Torres-Platas SG, Hercher C, Davoli MA et al. Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides. Neuropsychopharmacology 2011;36:2650-2658.
57. Giovannelli A, Limatola C, Ragozzino D et al. CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum. J Neuroimmunol 1998;92:122-132.
58. Puma C, Danik M, Quirion R, Ramon F, Williams S. The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J Neurochem 2001;78:960-971.
59. Lee WP, Tai DI, Lan KH et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res 2005;11:6431-6441.
60. Taguchi A, Ohmiya N, Shirai K et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 2005;14:2487-2493.
61. Ye BD, Kim SG, Park JH, Kim JS, Jung HC, Song IS. The interleukin-8-251 A allele is associated with increased risk of noncardia gastric adenocarcinoma in Helicobacter pylori-infected Koreans. J Clin Gastroenterol 2009;43:233-239.
62. Hu G, Schones DE, Cui K et al. Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1. Genome Res 2011;21:1650-1658.
63. Wei GH, Badis G, Berger MF et al. Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. EMBO J 2010;29:2147-2160.
64. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
65. Pique-Regi R, Degner JF, Pai AA, Gaffney DJ, Gilad Y, Pritchard JK. Accurate inference of transcription factor binding from DNA sequence and chromatin accessibility data. Genome Res 2011;21:447-455.
66. Nica AC, Parts L, Glass D et al. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet 2011;7:e1002003.